| Name | Shares allotted | % of global offering | % of post-IPO shares | Lock-up |
|---|---|---|---|---|
| Novotech SG Holdings Pte. Ltd. | 0 | 9.89% | — | 6 months |
| Silky Water Absolute Return LPF | 0 | 26.37% | — | 6 months |
| 百洋健康产业国际商贸有限公司 | 0 | 6.59% | — | 6 months |
| 富策控股有限公司 | 0 | 33.30% | — | 6 months |
| Rank | % of international placing | % of global offering |
|---|---|---|
| 前1名 | — | — |
The IPO saw a moderate oversubscription of 21.45 times, reflecting steady but not frenzied demand. The overall hit rate of 27.47% is relatively high, indicating ample allocation for most applicants. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
A-tail applicants applying HKD 200,000 were allocated an expected 0.4444 lots, nearly identical to B-head applicants with HKD 250,000 who received 0.4615 lots, making the marginal benefit of the higher tier negligible. Given the clawback reallocation, this inefficiency suggests B-head may incur higher broker fees for minimal extra allocation. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
The demographic breakdown shows zero participants recorded for both mainland and Hong Kong categories, likely due to data limitations, so no regional or demographic trends can be inferred. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
This page shows allotment analysis for Biostar Pharm-B (02563): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

